ICMR: Hydroxychloroquine could have side-effects

NEW DELHI: Healthcare workers who took anti-malaria drug hydroxychloroquine (HCQ) suffered from its side-effects like abdominal pain, nausea and hypoglycemia according to a study conducted by the Indian Council of Medical Research (ICMR).

ICMR head of epidemiology and communicable diseases, Dr R R Gangakhedkar said that “A study has been launched to know the side-effects of HCQ. We found that healthcare workers having an average age of 35 years took these drugs and 10% reported abdominal pain, 6% reported nausea and 1.3% reported hypoglycemia.”
“Around 22% of these healthcare workers also had other conditions like diabetes, cardiovascular diseases and blood pressure and therefore, probably out of fear, took HCQ as a preventive measure”, he further added.
“We are not doing a trial and we don’t have sufficient evidence base to do a trial. There will be about 480 patients who will be enrolled and it will go on for about 2.5 months,” Dr Gangakhedkar said.

ICMR is also researching to find out the other effects of HCQs.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid